In the News

The LDN 2021 Conference Recordings Now Available with up to 29 CME Credits [More Details]

Medical Professionals Become an LDN Specialist [More Details]

LDN Articles from general news sources

Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients (News)
Read More
FDA Grants Orphan Drug Status to Soin Therapeutics for Low Dose Naltrexone (LDN) to Treat Complex Regional Pain Syndrome (CRPS) (News)
Read More
Impact of Colchicine and Low-dose Naltrexone on COVID-19 (COLTREXONE) (Study)
Read More
What COVID-19 Teaches Us About Rare Diseases (News)
Read More
Low-Dose Naltrexone for Treating MS Symptoms (News)
Read More
Naltrexone reduces pain intensity and improves life for those with chronic pain, review suggests (News)
Read More
Covid-19 Long Haulers (News)
Read More
Phentermine Online Weight Loss Clinic Review - Where to buy best prescription diet pills (News)
Read More
LDN & Better Sleep (News)
Read More
Low Dose Naltrexone Easing Pain from Fibromyalgia and Other Painful Conditions (News)
Read More
Solutions for Small Intestinal Bacterial Overgrowth (News)
Read More
Low-dose Naltrexone Changes Levels of Inflammatory Proteins in MS, Study Shows (News)
Read More
Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells (News)
Read More
Low-dose naltrexone: tricking the body to heal itself (News)
Read More
The AMA’s Contribution to the Opioid Epidemic (News)
Read More
LDN Side Effect Survey Results 2021
Read More
Guest column: Don't neglect long-haul Covid in the panic over delta
Read More
Can common drugs offer 2-step approach to combat deadly virus? (News)
Read More
Medicine specialist talks treatments for lingering COVID-19 symptoms (News)
Read More
Low-Dose Naltrexone for Fibromyalgia and ME/CFS (News)
Read More
Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19 (Study)
Read More
Got Inflammation? How LDN can help in the times of Covid-19 (News)
Read More
LDN And Rheumatoid Arthritis (News)
Read More
AgelessRx Launches Pilot Post-COVID Clinical Trial Using LDN and NAD (News)
Read More
Scientists get first look at T cell responses in Ebola virus survivors (News)
Read More
How Chronic Pain Can Lead to Autoimmunity Problems (News)
Read More
McLaughlin leads research on identifying minimally invasive biomarkers for MS (News)
Read More
What is the evidence behind potential Low Dose Naltrexone benefits? (News)
Read More
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19) (News)
Read More
Low-Dose Naltrexone for Autoimmune and Chronic Pain Conditions, Podcast Interview (News)
Read More
Low-Dose Naltrexone Used as Alternative to Opioids for Chronic Pain Patients (News)
Read More
Calls for the radical treatment (News)
Read More
Low-Dose Naltrexone May Be Opioid Replacement for Chronic Pain (News)
Read More
Low Dose Naltrexone Emerging as Treatment for Intractable Pain (News)
Read More
Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 (Study)
Read More
Medicine specialist talks treatments for lingering COVID-19 symptoms (News)
Read More
Addiction Medication Promising for Chronic, Refractory Pain (News)
Read More
Low-dose naltrexone safe, effective for neuropathic corneal pain (News)
Read More
Synergistic Reduction of Schizophrenia in Animal Models using Low Dose Naltrexone and T Regulatory Cell Stimulation (News)
Read More
Low dose naltrexone: Harnessing the body's own chemistry to treat human ovarian cancer (News)
Read More
World-first laboratory study finds low-dose Naltrexone may improve ME/CFS symptoms (News)
Read More
The Use of Naltrexone in Low Doses Beyond the Approved Indication... (News)
Read More